Sg Americas Securities, LLC Sage Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$20.8 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	BUY	$16.75 - $48.98 $30,937 - $90,466	1,847 Added 11.02%	18,607 $383,000
Q2 2023 Jul 10, 2023	BUY	$40.65 - $59.54 $230,404 - $337,472	5,668 Added 51.1%	16,760 $788,000
Q1 2023 Apr 28, 2023	SELL	$37.27 - $46.57 $442,842 - $553,344	-11,882 Reduced 51.72%	11,092 $465,000
Q4 2022 Feb 02, 2023	BUY	$32.2 - $43.61 $401,920 - $544,340	12,482 Added 118.97%	22,974 $876,000
Q3 2022 Oct 31, 2022	SELL	$32.28 - $43.27 $451,564 - $605,304	-13,989 Reduced 57.14%	10,492 $411,000

Q2 2022 Jul 29, 2022	SELL	$27.52 - $37.99 $2.09 Million - $2.89 Million	-76,028 Reduced 75.64%	24,481 $791,000
Q1 2022 Apr 29, 2022	BUY	$30.71 - $45.71 $2.64 Million - $3.93 Million	86,031 Added 594.22%	100,509 $3.33 Million
Q4 2021 Feb 07, 2022	SELL	$37.06 - $47.11 $1.97 Million - $2.51 Million	-53,272 Reduced 78.63%	14,478 $616,000
Q3 2021 Nov 01, 2021	BUY	$40.26 - $57.37 $1.76 Million - $2.5 Million	43,599 Added 180.53%	67,750 $3 Million
Q2 2021 Aug 12, 2021	BUY	$54.88 - $79.29 $234,941 - $339,440	4,281 Added 21.55%	24,151 $1.37 Million
Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $116,501 - $159,557	-1,649 Reduced 7.66%	19,870 $1.49 Million
Q4 2020 Feb 04, 2021	BUY	$58.41 - $89.06 $238,780 - $364,077	4,088 Added 23.45%	21,519 $1.86 Million
Q3 2020 Nov 09, 2020	BUY	$41.13 - $62.45 $716,937 - $1.09 Million	17,431 New	17,431 $1.07 Million
Q4 2019 Jan 28, 2020	SELL	$60.18 - $154.77 $224,892 - $578,375	-3,737 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$140.29 - $189.96 $228,111 - $308,874	1,626 Added 77.03%	3,737 $524,000
Q2 2019 Jul 29, 2019	BUY	$157.85 - $183.09 $1,104 - $1,281	7 Added 0.33%	2,111 $387,000
Q1 2019 Apr 29, 2019	SELL	$89.33 - $163.65 $114,431 - $209,635	-1,281 Reduced 37.84%	2,104 $335,000
Q4 2018 Feb 01, 2019	BUY	$81.94 - $139.71 $66,371 - $113,165	810 Added 31.46%	3,385 $324,000
Q3 2018 Nov 06, 2018	BUY	$138.11 - $169.04 $232,024 - $283,987	1,680 Added 187.71%	2,575 $364,000
Q2 2018 Aug 07, 2018	SELL	$140.36 - $175.76 $608,881 - $762,446	-4,338 Reduced 82.9%	895 $140,000
Q1 2018 May 03, 2018	BUY	$152.15 - $192.33 $796,200 - $1.01 Million	5,233 New	5,233 $843,000
Q4 2017 Jan 24, 2018	SELL	$60.72 - $167.34 $413,746 - $1.14 Million	-6,814 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$61.4 - $88.52 $418,379 - $603,175	6,814	6,814 $425,000

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account